One21: A novel, customizable injection protocol for treatment of the forehead with incobotulinumtoxina

13Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It is well known that incobotulinumtoxinA (INCO) is an effective approved treatment for dynamic wrinkles of the upper face caused by the action of mimetic muscles over time. In doing so, it is important to maintain a balance between muscle groups and a natural facial appearance. Patients differ enormously in their facial anatomy regarding structure and function, both within and between genders, ethnicities, and age. Therefore, treating all patients with the same injection pattern and the same doses can result in undesired outcomes. There is a need for a tailored approach to achieve optimal results, as well as to increase patient satisfaction. With this in mind, the novel one21 injection technique which allows for individualized treatment has been developed for the treatment of horizontal forehead lines using INCO, resulting in a positive impact on eyebrow position and shape. This technique is the next step in a customized approach, giving natural-looking results and high patient satisfaction.

Cite

CITATION STYLE

APA

Pecora, C. de S. (2020). One21: A novel, customizable injection protocol for treatment of the forehead with incobotulinumtoxina. Clinical, Cosmetic and Investigational Dermatology, 13, 127–136. https://doi.org/10.2147/CCID.S237519

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free